Lund, Sweden, 16 December 2025. Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA), today announced that GOOD-IDES-02, a global pivotal Phase 3 trial in anti-glomerular basement membrane (anti-GBM) ...

Lund, Sweden, 16 December 2025. Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA), today announced that GOOD-IDES-02, a global pivotal Phase 3 trial in anti-glomerular basement membrane (anti-GBM) ...

The Swedish drugmaker has come up short in its effort to push imlifidase into treatment of the autoimmune condition ...

Discusses Progress in Blood-Purification Programs and DrugSorb-ATR's Regulatory Path December 15, 2025 11:00 AM ...

A U of A research team is working to discover potential treatments for neurodegenerative diseases like Huntington’s.

FAMU-FSU College of Engineering researchers are applying fuel cell technology to new applications like sustainable energy and ...

Researchers have developed a theoretical framework that shows how living cell membranes can generate electricity from ...

Unlike our organs, cell organelles such as mitochondria are not fixed in place, but when, where, how, and why organelles move ...

Extracorporeal membrane oxygenation (ECMO) technology has relative contraindications in haemorrhagic disease but remains an effective therapeutic option for the treatment of pulmonary haemorrhage ...

Up-to-date computational pipeline characterizes G-protein-coupled receptor (GPCR) repertoires in the closest relatives of metazoans, providing a framework to investigate the evolutionary origins and ...

The PINOID (PID) protein kinase is required for flower initiation in Arabidopsis. The pid mutants fail to initiate flowers on inflorescences, a phenotype that is mimicked by disrupting either the ...

Scientists have discovered that T cell receptors activate through a hidden spring-like motion that had never been seen before ...